Navigation Links
Pfizer, Merck, Roche/Genentech, GSK, J&J, BMS and More to Speak at Contracting & Outsourcing 2010
Date:9/16/2010

NEW BRUNSWICK, N.J., Sept. 15 /PRNewswire/ -- On Sept. 23 and 24, the Hyatt Regency in New Brunswick, N.J. will host Contracting & Outsourcing 2010, the 9th annual Conference and Tabletop Exhibition held by Contract Pharma Magazine. This year's Conference will feature a keynote presentation by Mac Lynch, Vice President, Contract Manufacturing at Pfizer, covering Global Pharma Outsourcing Trends. Other speakers and panelists represent FDA, Johnson & Johnson, Roche/Genentech, Bristol-Myers Squibb, Merck, GlaxoSmithKline and more.

Contracting & Outsourcing 2010 will feature presentations and panels discussing a wide array of pharma and biopharma outsourcing and contract service topics, including far east outsourcing, sponsor-provider partnerships, CMO management, FDA compliance enforcement, clinical trial management, inspection issues and more. The conference will also include a panel on Contract Laboratory Criteria and the inaugural Executive Outsourcing Summit, with participants from across the drug development spectrum.

The event will feature a one-day Tabletop Exhibition on Sept. 23. With 160 contract service providers and vendors in attendance, the Exhibit Hall will cover virtually every aspect of the drug development and commercialization continuum.

Networking opportunities are enhanced by a Cocktail Reception at the end of the first day. Sponsored by Catalent Pharma Solutions, the reception offers an informal atmosphere for conversation and deal-making. The mix of presentations and exhibitions promises value to attendees from large pharma and biopharma companies as well as those from emerging and startup firms.

A full list of exhibitors can be found at http://contractpharma.com/2010conference/exhibitor_list

The schedule for Contracting & Outsourcing, as well as bios of all speakers, can be found at http://contractpharma.com/2010conference/speakers_and_topics

Attendee registration costs $395 and covers all conference and exhibit hall  sessions, lunch, refreshment breaks, and the Networking Reception. Registration is available online at http://regonline.com/cpa10 or by walkup at the Hyatt Regency in New Brunswick, NJ.

Now in its ninth year, Contracting & Outsourcing is the premier event for pharma and biopharma contract services and outsourcing.

For additional information about Contracting & Outsourcing 2010, visit http://contractpharma.com/2010conference or contact Kristin Brooks at +1-201-880-2226 or kbrooks@rodpub.com. For more about Contract Pharma, the top magazine worldwide for pharma and biopharma contract services and outsourcing, visit http://contractpharma.com


'/>"/>
SOURCE Contract Pharma Magazine
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. WWMR Announces Pain Clinic Physicians Most Appreciated Companies: Pfizer, Eli Lilly and Endo Pharmaceuticals
2. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
3. Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors
4. Neuralstem CEO to Speak on ALS Panel at World Stem Cell Summit
5. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
6. MedNet Solutions to Speak, Sponsor and Exhibit at the 2008 Society of Clinical Data Management Annual Conference in Dallas
7. Former Speaker of the House Newt Gingrich Featured Wednesday
8. Brain and Hearing Pioneer, Michael Merzenich, Ph.D. to Speak at Case Western Reserve University
9. Verenium Corporation to Speak at the Credit Suisse Alternative Energy Conference
10. Dr. Gail Naughton Speaks on Histogen's Business Plan and the Rise of Bioaesthetic Medicine during Commercial Translation of Regenerative Medicine
11. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest ... ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials in ...
Breaking Biology Technology:
(Date:3/31/2016)... March 31, 2016   ... or the "Company") LegacyXChange is excited to ... its soon to be launched online site for trading ... ) will also provide potential shareholders a sense ... technology to an industry that is notorious for fraud. ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
Breaking Biology News(10 mins):